Logo image of LXS.DE

LANXESS AG (LXS.DE) Stock Fundamental Analysis

Europe - FRA:LXS - DE0005470405 - Common Stock

22.72 EUR
-0.18 (-0.79%)
Last: 9/18/2025, 5:36:15 PM
Fundamental Rating

3

LXS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 66 industry peers in the Chemicals industry. LXS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LXS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year LXS was profitable.
LXS had a positive operating cash flow in the past year.
LXS had positive earnings in 4 of the past 5 years.
Each year in the past 5 years LXS had a positive operating cash flow.
LXS.DE Yearly Net Income VS EBIT VS OCF VS FCFLXS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

LXS has a worse Return On Assets (-1.96%) than 65.15% of its industry peers.
LXS has a Return On Equity of -4.13%. This is in the lower half of the industry: LXS underperforms 63.64% of its industry peers.
Industry RankSector Rank
ROA -1.96%
ROE -4.13%
ROIC N/A
ROA(3y)1.66%
ROA(5y)3.5%
ROE(3y)3.89%
ROE(5y)9.65%
ROIC(3y)N/A
ROIC(5y)N/A
LXS.DE Yearly ROA, ROE, ROICLXS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

In the last couple of years the Operating Margin of LXS has declined.
LXS has a worse Gross Margin (21.19%) than 69.70% of its industry peers.
LXS's Gross Margin has declined in the last couple of years.
LXS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.19%
OM growth 3Y-49.18%
OM growth 5Y-37.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
LXS.DE Yearly Profit, Operating, Gross MarginsLXS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

4

2. Health

2.1 Basic Checks

LXS does not have a ROIC to compare to the WACC, probably because it is not profitable.
LXS has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, LXS has more shares outstanding
The debt/assets ratio for LXS has been reduced compared to a year ago.
LXS.DE Yearly Shares OutstandingLXS.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LXS.DE Yearly Total Debt VS Total AssetsLXS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

LXS has an Altman-Z score of 1.95. This is not the best score and indicates that LXS is in the grey zone with still only limited risk for bankruptcy at the moment.
LXS has a Altman-Z score (1.95) which is in line with its industry peers.
LXS has a debt to FCF ratio of 22.23. This is a negative value and a sign of low solvency as LXS would need 22.23 years to pay back of all of its debts.
With a Debt to FCF ratio value of 22.23, LXS perfoms like the industry average, outperforming 53.03% of the companies in the same industry.
A Debt/Equity ratio of 0.60 indicates that LXS is somewhat dependend on debt financing.
The Debt to Equity ratio of LXS (0.60) is worse than 60.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 22.23
Altman-Z 1.95
ROIC/WACCN/A
WACC4.76%
LXS.DE Yearly LT Debt VS Equity VS FCFLXS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 2.41 indicates that LXS has no problem at all paying its short term obligations.
LXS has a better Current ratio (2.41) than 74.24% of its industry peers.
A Quick Ratio of 1.24 indicates that LXS should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.24, LXS perfoms like the industry average, outperforming 59.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.41
Quick Ratio 1.24
LXS.DE Yearly Current Assets VS Current LiabilitesLXS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 244.27% over the past year.
LXS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -19.38% yearly.
LXS shows a decrease in Revenue. In the last year, the revenue decreased by -2.75%.
Measured over the past years, LXS shows a decrease in Revenue. The Revenue has been decreasing by -1.32% on average per year.
EPS 1Y (TTM)244.27%
EPS 3Y-31.1%
EPS 5Y-19.38%
EPS Q2Q%-1.67%
Revenue 1Y (TTM)-2.75%
Revenue growth 3Y1.43%
Revenue growth 5Y-1.32%
Sales Q2Q%-12.63%

3.2 Future

Based on estimates for the next years, LXS will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.75% on average per year.
Based on estimates for the next years, LXS will show a small growth in Revenue. The Revenue will grow by 0.57% on average per year.
EPS Next Y-91.13%
EPS Next 2Y1.79%
EPS Next 3Y9.63%
EPS Next 5Y11.75%
Revenue Next Year-6.71%
Revenue Next 2Y-2.49%
Revenue Next 3Y-0.55%
Revenue Next 5Y0.57%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LXS.DE Yearly Revenue VS EstimatesLXS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
LXS.DE Yearly EPS VS EstimatesLXS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.02, which indicates a correct valuation of LXS.
87.88% of the companies in the same industry are more expensive than LXS, based on the Price/Earnings ratio.
LXS is valuated cheaply when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 13.88, which indicates a correct valuation of LXS.
LXS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. LXS is cheaper than 71.21% of the companies in the same industry.
LXS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.02
Fwd PE 13.88
LXS.DE Price Earnings VS Forward Price EarningsLXS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LXS is valued a bit cheaper than the industry average as 77.27% of the companies are valued more expensively.
78.79% of the companies in the same industry are more expensive than LXS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.52
EV/EBITDA 6.19
LXS.DE Per share dataLXS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.79%
EPS Next 3Y9.63%

0

5. Dividend

5.1 Amount

LXS has a yearly dividend return of 0.43%, which is pretty low.
Compared to an average industry Dividend Yield of 3.04, LXS is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.38, LXS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.43%

5.2 History

The dividend of LXS decreases each year by -35.08%.
Dividend Growth(5Y)-35.08%
Div Incr Years0
Div Non Decr Years1
LXS.DE Yearly Dividends per shareLXS.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of LXS are negative and hence is the payout ratio. LXS will probably not be able to sustain this dividend level.
DP-6.06%
EPS Next 2Y1.79%
EPS Next 3Y9.63%
LXS.DE Yearly Income VS Free CF VS DividendLXS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

LANXESS AG

FRA:LXS (9/18/2025, 5:36:15 PM)

22.72

-0.18 (-0.79%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners57.91%
Inst Owner ChangeN/A
Ins Owners2.86%
Ins Owner ChangeN/A
Market Cap1.96B
Analysts56.3
Price Target27.35 (20.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.43%
Yearly Dividend0.1
Dividend Growth(5Y)-35.08%
DP-6.06%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)342.83%
Min EPS beat(2)179.44%
Max EPS beat(2)506.23%
EPS beat(4)4
Avg EPS beat(4)291.96%
Min EPS beat(4)130.13%
Max EPS beat(4)506.23%
EPS beat(8)7
Avg EPS beat(8)214.49%
EPS beat(12)11
Avg EPS beat(12)158.11%
EPS beat(16)14
Avg EPS beat(16)122.5%
Revenue beat(2)0
Avg Revenue beat(2)-5.13%
Min Revenue beat(2)-8.49%
Max Revenue beat(2)-1.78%
Revenue beat(4)0
Avg Revenue beat(4)-4.88%
Min Revenue beat(4)-8.49%
Max Revenue beat(4)-1.78%
Revenue beat(8)1
Avg Revenue beat(8)-5.19%
Revenue beat(12)3
Avg Revenue beat(12)-2.77%
Revenue beat(16)3
Avg Revenue beat(16)-5.61%
PT rev (1m)-3.5%
PT rev (3m)-6.58%
EPS NQ rev (1m)-83.55%
EPS NQ rev (3m)-178.28%
EPS NY rev (1m)-91.35%
EPS NY rev (3m)-91.35%
Revenue NQ rev (1m)-3.17%
Revenue NQ rev (3m)-8.49%
Revenue NY rev (1m)-3.08%
Revenue NY rev (3m)-5.38%
Valuation
Industry RankSector Rank
PE 12.02
Fwd PE 13.88
P/S 0.32
P/FCF 17.52
P/OCF 4.45
P/B 0.49
P/tB 1.13
EV/EBITDA 6.19
EPS(TTM)1.89
EY8.32%
EPS(NY)1.64
Fwd EY7.21%
FCF(TTM)1.3
FCFY5.71%
OCF(TTM)5.11
OCFY22.48%
SpS71.2
BVpS46.22
TBVpS20.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.96%
ROE -4.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.19%
FCFM 1.82%
ROA(3y)1.66%
ROA(5y)3.5%
ROE(3y)3.89%
ROE(5y)9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-49.18%
OM growth 5Y-37.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
F-Score6
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 22.23
Debt/EBITDA 4.11
Cap/Depr 51.65%
Cap/Sales 5.35%
Interest Coverage N/A
Cash Conversion 75.26%
Profit Quality N/A
Current Ratio 2.41
Quick Ratio 1.24
Altman-Z 1.95
F-Score6
WACC4.76%
ROIC/WACCN/A
Cap/Depr(3y)54.6%
Cap/Depr(5y)69.53%
Cap/Sales(3y)4.97%
Cap/Sales(5y)6.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)244.27%
EPS 3Y-31.1%
EPS 5Y-19.38%
EPS Q2Q%-1.67%
EPS Next Y-91.13%
EPS Next 2Y1.79%
EPS Next 3Y9.63%
EPS Next 5Y11.75%
Revenue 1Y (TTM)-2.75%
Revenue growth 3Y1.43%
Revenue growth 5Y-1.32%
Sales Q2Q%-12.63%
Revenue Next Year-6.71%
Revenue Next 2Y-2.49%
Revenue Next 3Y-0.55%
Revenue Next 5Y0.57%
EBIT growth 1Y92.44%
EBIT growth 3Y-48.45%
EBIT growth 5Y-38.23%
EBIT Next Year1226.47%
EBIT Next 3Y155.37%
EBIT Next 5Y77.89%
FCF growth 1Y250%
FCF growth 3YN/A
FCF growth 5Y6.85%
OCF growth 1Y6.52%
OCF growth 3Y7.67%
OCF growth 5Y-4.6%